Phase II trials in mesothelioma: an increasing challenge

Lung Cancer. 2005 Oct;50(1):87-90. doi: 10.1016/j.lungcan.2005.05.024.

Author

Affiliation

¹ Department of Medicine and Pharmacology, University of Western Australia, Hospital Avenue, Nedlands, WA 6009, Australia.

PMID: 16026892
DOI: 10.1016/j.lungcan.2005.05.024

No abstract available

MeSH terms

Clinical Trials, Phase II as Topic*
Endpoint Determination
Humans
Mesothelioma / drug therapy*
Mesothelioma / pathology
Pleural Neoplasms / drug therapy*
Pleural Neoplasms / pathology
Prognosis
Quality of Life
Research Design
Survival Analysis